arrow
T

Toshiki Tezuka

keio university
H指数:10
被引数:419

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Florzolotau (18F) retention is linked to neuropsychological performance in tauopathy

Florzolotau (18F)的滞留与tauopathy患者的神经心理学表现相关。

2026-04-010
OAAI
Association Between a One-Year Group-Based Telerehabilitation Program and the Quality of Life of People with Parkinson's Disease: An Observational Study

与为期一年的基于小组的远程康复计划与帕金森病患者生活质量关联性的观察性研究

2026-02-080
PREAI
Levodopa Pharmacokinetics in Switching From Levodopa/Carbidopa Intestinal Gel to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in a Patient With Parkinson's Disease: A Case Report

左旋多巴药代动力学:从左旋多巴/卡比多巴肠凝胶转换为连续皮下福司左旋多巴/福司卡比多巴输注在帕金森病患者中的研究:一个病例报告

2025-01-061
OA
Can the clinical sign head-turning sign and simple questions in Neucop-Q predict amyloid β pathology?
2024-11-210
OAAI
Clinical characteristics and pathophysiological properties of newly discovered LRRK2 variants associated with Parkinson's disease

新发现的与帕金森病相关的LRRK2变异体的临床特征和病理生理特性

2024-09-011
OAAI
Validation study of the Japanese version of the King's Parkinson's Disease Pain Scale and the King's Parkinson's Disease Pain Questionnaire

日本版《帕金森病疼痛量表》和《帕金森病疼痛问卷》的验证研究

2024-03-012
OAAI
Performance of plasma Aβ42/40, measured using a fully automated immunoassay, across a broad patient population in identifying amyloid status
2023-09-0410
OAAI
Impact of Amyloid and Tau PET on Changes in Diagnosis and Patient Management
2023-01-1712
PRE
Evaluation of [18F]PI-2620, a second-generation selective tau tracer, for assessing four-repeat tauopathies

评估第二代选择性tau示踪剂 [18F] 2620,用于评估四重复tau病变

2021-08-2453
OAAI